Kathryn C. Zoon - Mar 12, 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role
Director
Signature
/s/ Richard S. Lindahl, Attorney-in-fact
Stock symbol
EBS
Transactions as of
Mar 12, 2025
Transactions value $
-$57,300
Form type
4
Date filed
3/12/2025, 06:13 PM
Previous filing
Jun 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EBS Common Stock Sale -$57.3K -10K -18.35% $5.73 44.5K Mar 12, 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.